Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply.
Saved in:
| Title: | Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply. |
|---|---|
| Authors: | Kim WR; Stanford University School of Medicine, Stanford, CA, USA., Telep LE; Gilead Sciences Inc., Foster City, CA, USA., Chokkalingam AP; Gilead Sciences Inc., Foster City, CA, USA. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 May; Vol. 55 (10), pp. 1344-1345. |
| Publication Type: | Editorial; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
